The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years (Q73459311)
Jump to navigation
Jump to search
scientific article published on 01 February 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years |
scientific article published on 01 February 2000 |
Statements
The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years (English)
W Reed
E Hannisdal
P J Boehler
S Gundersen
H Host
1 February 2000